Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2012 December;64(6) > Minerva Ginecologica 2012 December;64(6):501-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

  REPRODUCTIVE MEDICINE 

Minerva Ginecologica 2012 December;64(6):501-5

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: English

PCOS: metabolic impact and long-term management

Carmina E.

Androgen Excess and PCOS Society, DISMOT Department, University of Palermo, Palermo, Italy


PDF


Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in women, affecting up to 10% of those in reproductive age. Furthermore, PCOS presents a lifetime risk of type II diabetes, cardiovascular diseases and endometrial cancer. Women with PCOS have increased cardiovascular risk; however, the risk is not the same in all patients and it is necessary to assess an individual risk profile. There is a discrepancy between increased cardiovascular risk at young age and postmenopausal number of cardiovascular events, probablu depending on changes in androgen ovarian function after the forties. However, changes with age of metabolic profile in women with PCOS have not been studied yet and many more data are necessary.

top of page